US Patent Issued to Regeneron Pharmaceuticals on Nov. 25 for "Methods for analysis of viral capsid protein composition" (New York Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,139, issued on Nov. 25, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods for analysis of viral capsid protein composition" was invented by Shunhai Wang (Scarsdale, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of determining the stoichiometry of a viral capsid and/or determining the heterogeneity of protein components in a viral capsid are described."

The patent was filed on Nov. 15, 2023, under Application No. 18/509,781.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=...